Union Square Park Capital Management, LLC Acer Therapeutics Inc. Transaction History

Union Square Park Capital Management, LLC

  • $113 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.57 - $1.28 $15,180 - $34,090
26,633 New
26,633 $21,000

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0
View Full List

About Acer Therapeutics Inc.

ACER Quotes by TradingView
  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Union Square Park Capital Management, LLC Portfolio

Follow Union Square Park Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Union Square Park Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Union Square Park Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email